Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

Huonslab, a subsidiary of Huons Global and a major player in recombinant human hyaluronidase-based biologics Sub-Q delivery, announced on Nov. 11 that it has completed patent filing and examination ...

Ken D. Kumayama and Pramode Chiruvolu of Skadden, Arps, Slate, Meagher & Flom LLP discuss intellectual property protections ...

Encouraged and abetted by free riders who would benefit unfairly from others’ work, well-intentioned lawmakers and judicial ...

The US Patent and Trademark Office (USPTO ... USPTO DIRECTOR MAINTAINS SIGNIFICANT FLEXIBILITY IN DIRECTOR REVIEW PROCEDURES Consistent with the interim process, the Director retains significant ...

And second, with the Supreme Court's decision in September to deny serve, the legal process with respect to the 3 patents ...

What started off as a dice roll of a new practice group at Russ August & Kabat has turned into the breadwinner of the ...

While the larger steelmakers saw the most upheaval in the 1970s, facing increasing competition from foreign makers and other ...

Today, Palworld developer Pocketpair published a report detailing the terms of the intellectual property lawsuit Nintendo ...

A recent executive order prompted the US Patent and Trademark Office to publish a new guideline ... the claim limitations ...